New Alzheimer's Drug Found to Slow Cognitive Decline

Advertise with us

Advertise with us

International News

FDA

Alzheimer's Drug that Slows Cognitive Decline Gets FDA Approval

The US Food and Drug Administration granted accelerated approval for the Alzheimer's disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline. The FDA said the drug is for pati..
U.S. FDA advisers overwhelmingly back Moderna COVID vaccine for ages 6-17

Advisers to the U.S. Food and Drug Administration on Tuesday unanimously recommended that the agency authorize Moderna Inc's (MRNA.O) COVID-19 vaccine for children and teens aged 6 to 17 years of age. Around 77 million people in the ..
U.S. FDA approves Gilead's COVID-19 drug for young children

The U.S. drug regulator on Monday granted the first full approval for treating COVID-19 in children aged 28 days and older to Gilead Sciences Inc's (GILD.O) drug remdesivir. The move comes months after...
U.S. FDA approves new Bristol Myers cancer immunotherapy

Bristol Myers Squibb Co (BMY.N) said on Friday that U.S. regulators approved the first drug in a new class of cancer immunotherapies as an initial treatment for advanced melanoma, the deadliest form of skin cancer. The company said it expects the ..
FDA clears use of Lilly's COVID-19 antibody therapy for kids

The U.S. Food and Drug Administration on Friday authorized the use of Eli Lilly's (LLY.N) COVID-19 dual-antibody therapy in treating mild to moderate symptoms in all children, including newborns, who are at risk of severe illness. The therapy,..
FDA officials back Pfizer jab for children over five in US

A US government panel has voted to recommend the Pfizer/BioNTech vaccine should to be given to children aged five to 11. The Food and Drug Administration (FDA) experts backed the move on Tuesday, paving the way for emergency authorisation within a..
FDA panel endorses lower-dose Moderna COVID shot for booster

U.S. health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine at least six months ago should get a half-dose booster to rev up protection against the coronavirus. The panel of outside advisers to the Food and..
U.S. FDA seeks new warnings on arthritis drugs from Pfizer, Lilly and AbbVie

REUTERS The U.S. drug regulator has asked Pfizer (PFE.N), Eli Lilly & Co (LLY.N) and AbbVie
Pfizer becomes first Covid vaccine to gain full FDA approval

BBC Pfizer's two-dose Covid-19 vaccine has received full approval from the US Food and Drug Administration (FDA) - the first jab to be licensed in the nation. The vaccine had initially been given emergency use authorisation. Its two jabs,....

Desert Falls Live a Little — VIDEO OF THE WEEK

Follow US

categories